BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 31361529)

  • 1. Utility of Multiparametric MRI for Predicting Residual Clinically Significant Prostate Cancer After Focal Laser Ablation.
    Felker ER; Raman SS; Lu DSK; Tuttle M; Margolis DJ; ElKhoury FF; Sayre J; Marks LS
    AJR Am J Roentgenol; 2019 Dec; 213(6):1253-1258. PubMed ID: 31361529
    [No Abstract]   [Full Text] [Related]  

  • 2. Intra- and interreader reproducibility of PI-RADSv2: A multireader study.
    Smith CP; Harmon SA; Barrett T; Bittencourt LK; Law YM; Shebel H; An JY; Czarniecki M; Mehralivand S; Coskun M; Wood BJ; Pinto PA; Shih JH; Choyke PL; Turkbey B
    J Magn Reson Imaging; 2019 Jun; 49(6):1694-1703. PubMed ID: 30575184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRI-based monitoring of prostate cancer after HIFU: Inter-reader agreement and diagnostic performance of the PI-FAB score.
    Pausch AM; Elsner C; Rupp NJ; Eberli D; Hötker AM
    Eur J Radiol; 2024 Jun; 175():111463. PubMed ID: 38615502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Association of Tissue Change and Treatment Success During High-intensity Focused Ultrasound Focal Therapy for Prostate Cancer.
    Khandwala YS; Soerensen SJC; Morisetty S; Ghanouni P; Fan RE; Vesal S; Rusu M; Sonn GA
    Eur Urol Focus; 2023 Jul; 9(4):584-591. PubMed ID: 36372735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate Imaging after Focal Ablation (PI-FAB): A Proposal for a Scoring System for Multiparametric MRI of the Prostate After Focal Therapy.
    Giganti F; Dickinson L; Orczyk C; Haider A; Freeman A; Emberton M; Allen C; Moore CM
    Eur Urol Oncol; 2023 Dec; 6(6):629-634. PubMed ID: 37210343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRI-guided focal laser ablation of prostate cancer: a prospective single-arm, single-center trial with 3 years of follow-up.
    Mehralivand S; George AK; Hoang AN; Rais-Bahrami S; Rastinehad AR; Lebastchi AH; Ahdoot M; Siddiqui MM; Bloom J; Sidana A; Merino MJ; Choyke PL; Shih JH; Turkbey B; Wood BJ; Pinto PA
    Diagn Interv Radiol; 2021 May; 27(3):394-400. PubMed ID: 34003127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating Diagnostic Accuracy and Inter-reader Agreement of the Prostate Imaging After Focal Ablation Scoring System.
    Gelikman DG; Kenigsberg AP; Mee Law Y; Yilmaz EC; Harmon SA; Parikh SH; Hyman JA; Huth H; Koller CR; Nethala D; Hesswani C; Merino MJ; Gurram S; Choyke PL; Wood BJ; Pinto PA; Turkbey B
    Eur Urol Open Sci; 2024 Apr; 62():74-80. PubMed ID: 38468864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First experiences using transurethral ultrasound ablation (TULSA) as a promising focal approach to treat localized prostate cancer: a monocentric study.
    Peters I; Hensen B; Glandorf J; Gutberlet M; Dohna M; Struckmann S; Kuczyk MA; Wacker F; Hellms S
    BMC Urol; 2023 Aug; 23(1):142. PubMed ID: 37644453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current magnetic resonance imaging-based diagnostic strategies for prostate cancer.
    Inoue T; Shin T
    Int J Urol; 2023 Dec; 30(12):1078-1086. PubMed ID: 37592819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reply to Jorge Abreu-Gomez, Masoom Haider, and Sangeet Ghai's Letter to the Editor re: Francesco Giganti, Louise Dickinson, Clement Orczyk, et al. Prostate Imaging after Focal Ablation (PI-FAB): A Proposal for a Scoring System for Multiparametric MRI of the Prostate After Focal Therapy. Eur Urol Oncol. 2023;6:629-634.
    Giganti F; Dickinson L; Allen C; Moore CM
    Eur Urol Oncol; 2024 Apr; 7(2):308. PubMed ID: 37722978
    [No Abstract]   [Full Text] [Related]  

  • 11. A Quantitative Multiparametric MRI Analysis Platform for Estimation of Robust Imaging Biomarkers in Clinical Oncology.
    LoCastro E; Paudyal R; Konar AS; LaViolette PS; Akin O; Hatzoglou V; Goh AC; Bochner BH; Rosenberg J; Wong RJ; Lee NY; Schwartz LH; Shukla-Dave A
    Tomography; 2023 Nov; 9(6):2052-2066. PubMed ID: 37987347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transperineal laser ablation (TPLA) with ultrasound/MRI fusion guidance in the treatment of localized radiotherapy-resistant prostate cancer.
    Manenti G; Nezzo M; Ryan CP; Fraioli FR; Carreri B; Gigliotti PE; Angeloni C; Di Pietro F; De Angeli M; Perretta T; D'Angelillo RM; Garaci FG
    BJR Open; 2023; 5(1):20230042. PubMed ID: 37942495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transperineal Laser Ablation (TPLA) Treatment of Focal Low-Intermediate Risk Prostate Cancer.
    Manenti G; Perretta T; Nezzo M; Fraioli FR; Carreri B; Gigliotti PE; Micillo A; Malizia A; Di Giovanni D; Ryan CP; Garaci FG
    Cancers (Basel); 2024 Apr; 16(7):. PubMed ID: 38611082
    [No Abstract]   [Full Text] [Related]  

  • 14. MRI-guided Minimally Invasive Focal Therapies for Prostate Cancer.
    Alabousi M; Ghai S; Haider MA
    Radiology; 2023 Dec; 309(3):e230431. PubMed ID: 38051187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unlocking the Benefits of Multiparametric MRI for Predicting Prostate Cancer Recurrence.
    Aguirre DA; Cardona Ortegón JD
    Radiology; 2023 Nov; 309(2):e232819. PubMed ID: 37987663
    [No Abstract]   [Full Text] [Related]  

  • 16. Re: Matthias Boschheidgen, Peter Albers, Heinz-Peter Schlemmer, et al. Multiparametric Magnetic Resonance Imaging in Prostate Cancer Screening at the Age of 45 Years: Results from the First Screening Round of the PROBASE Trial, Eur Urol 2024:85:105-111.
    Huang TB; Ding XF
    Eur Urol; 2024 Apr; 85(4):e112. PubMed ID: 38105141
    [No Abstract]   [Full Text] [Related]  

  • 17. Re: Multiparametric MRI is not sufficient for prostate cancer staging: A single institutional experience validated by a multi-institutional regional collaborative. Thenappan Chandrasekar, Andrew Denisenko, Vasil Mico and Colleagues. Urological Oncology: Seminars and Original Investigations 41 (2023) 355.e1-355.e8.
    Dinneen E; Kasivisvanathan V; Giganti F; Allen C; Shaw G; Punwani S
    Urol Oncol; 2024 Jan; 42(1):18-19. PubMed ID: 37968168
    [No Abstract]   [Full Text] [Related]  

  • 18. Contemporary patterns of local ablative therapies for prostate cancer at United States cancer centers: results from a national registry.
    Koelker M; Labban M; Frego N; Meyer CP; Salomon G; Lipsitz SR; Withington J; Moore CM; Tempany CM; Tuncali K; George A; Kibel AS; Trinh QD; Cole AP
    World J Urol; 2023 May; 41(5):1309-1315. PubMed ID: 36930254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AI-based automated evaluation of image quality and protocol tailoring in patients undergoing MRI for suspected prostate cancer.
    Kluckert J; Hötker AM; Da Mutten R; Konukoglu E; Donati OF
    Eur J Radiol; 2024 Jun; 177():111581. PubMed ID: 38925042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Model-based planning and real-time predictive control for laser-induced thermal therapy.
    Feng Y; Fuentes D
    Int J Hyperthermia; 2011; 27(8):751-61. PubMed ID: 22098360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.